Posters

Long-term efficacy of Tafluprost UD: three case reports

Poster Details

First Author: J.Benitez-del-Castillo SPAIN

Co Author(s):    D. Morillo-Rojas   A. Soto-Guerrero   I. Mota-Chozas              

Abstract Details

Purpose:

To show cases of long-term efficacy of tafluprost U.D. (alone or in combination) controlled with functional and structural tests in three different clinical situations.

Setting:

Hospital Universitario del S.A.S. de Jerez (Spain)

Methods:

Follow-up study with intraocular pressure (IOP) monitoring (Goldmann applanation tonometry in the same morning time slot, GAT), functional (visual field, VF) and structural (peripapillary retinal nerve fiber layer thickness and optic nerve head tomography measured with optical coherence tomography, CFNR and ONH OCT) tests of three different patients treated with tafluprost U.D. in the evening: ocular hypertension, pre-perimetric glaucoma and primary open-angle glaucoma (POAG)

Results:

Ocular Hypertension: November-2013 initial IOP OD 24 mmHg and OS 26 mmHg, 48 months follow-up, tafluprost OU, last visit IOP OD 12 mmHg and OS 12 mmHg, functionally and structurally controlled. Pre-perimetric glaucoma (OS): March-2010 initial IOP OD 28 mmHg and OS 28 mmHg, 106 months follow-up, tafluprost OU, last visit IOP OD 14 mmHg and OS 14 mmHg, functionally and structurally controlled. POAG: May-2011 initial IOP OD 24 mmHg and IOP OS 26 mmHg, 91 months follow-up, initially tafluprost, after with timolol OU, last visit IOP OD 12 mmHg and IOP OS 12 mmHg, functionally and structurally controlled.

Conclusions:

In a real-world setting, we can see how tafluprost U.D. maintains its ocular hypotensive effect in the long-term and three different patient profiles are functionally and structurally controlled.

Financial Disclosure:

None